Constellium (CSTM) Misses Q2 EPS by EUR0.66

Constellium (NYSE: CSTM) reported Q2 EPS of (EUR0.24), EUR0.66 worse than the analyst estimate of EUR0.42. Revenue for the quarter came in at EUR2.3 billion versus the consensus estimate of EUR2.05 billion.

Outlook:

Based on our current outlook, we expect Adjusted EBITDA in the range of €670 million to €690 million in 2022.

For earnings history and earnings-related data on Constellium (CSTM) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance